首站-论文投稿智能助手
典型文献
Antitumor pharmacological research in the era of personalized medicine
文献摘要:
Anticancer drug discovery has yielded unprecedented progress in recent decades,resulting in the approval of innovative treatment options for patients and the successful implementation of personalized medicine in clinical practice.This remarkable progress has also reshaped the research scope of pharmacological research.This article,as a tribute to cancer research at Shanghai Institute of Materia Medica in celebration of the institute's 90th birthday,provides an overview of the conceptual revolution occurring in anticancer therapy,and summarizes our recent progress in the development of molecularly targeted therapeutics and exploration of new strategies in personalized medicine.With this review,we hope to provide a glimpse into how antitumor pharmacological researchers have embraced the new era of personalized medicine research and to propose a future path for anticancer drug discovery and pharmacological research.
文献关键词:
作者姓名:
Min Huang;Mei-yu Geng;Jian Ding
作者机构:
State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China
引用格式:
[1]Min Huang;Mei-yu Geng;Jian Ding-.Antitumor pharmacological research in the era of personalized medicine)[J].中国药理学报(英文版),2022(12):3015-3020
A类:
embraced
B类:
Antitumor,pharmacological,personalized,medicine,Anticancer,drug,discovery,has,yielded,unprecedented,progress,recent,decades,resulting,approval,innovative,treatment,options,patients,successful,implementation,clinical,practice,This,remarkable,also,reshaped,scope,article,tribute,Shanghai,Institute,Materia,Medica,celebration,institute,90th,birthday,provides,overview,conceptual,revolution,occurring,anticancer,therapy,summarizes,our,development,molecularly,targeted,therapeutics,exploration,new,strategies,With,this,review,we,hope,glimpse,into,how,antitumor,researchers,have,propose,future,path
AB值:
0.617838
相似文献
The mini player with diverse functions:extracellular vesicles in cell biology,disease,and therapeutics
Abhimanyu Thakur;Xiaoshan Ke;Ya-Wen Chen;Pedram Motalllebnejad;Kui Zhang;Qizhou Lian;Huanhuan Joyce Chen-The Pritzker School of Molecular Engineering,The University of Chicago,Chicago,Illinois,USA;The Ben May Department for Cancer Research,The University of Chicago,Chicago,Illinois,USA;Division of Pulmonary,Critical Care and Sleep Medicine,Department of Medicine,Keck School of Medicine,Hastings Center for Pulmonary Research,University of Southern California,Los Angeles,CA 90089,USA;Department of Stem Cell Biology and Regenerative Biology,Keck School of Medicine,University of Southern California,Los Angeles,CA 90089,USA;Department of Medicine,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Pok Fu Lam,Hong Kong;Prenatal Diagnostic Center and Cord Blood Bank,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou,China;HKUMed Laboratory of Cellular Therapeutics,the University of Hong Kong,Pok Fu Lam,Hong Kong
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
Yang Liu;Ning Zhang;Cuicui Xie;Yale Jiang;Yunhe Qin;Liyun Zhou;Yi Fan;Lianjie Ren;Chen Yin;Huan Yang;Wei Xie;Qing Zhai;Guanqiao Li;Hongzhuan Chen;Xiaoyuan Chen-Tsinghua Clinical Research Institute(TCRI),School of Medicine,Tsinghua University,Beijing 100084,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100038,China;Pharmcube(Beijing)Co.,Ltd.,Beijing 100102,China;Department of Clinical Pharmacy,Cancer Hospital of Fudan University,Shanghai 200032,China;Vanke School of Public Health,Tsinghua University,Beijing 100084,China;Shanghai Collaborative Innovation Center for Translational Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Office of Clinical Trial Institute,Beijing Tsinghua Changgung Hospital,Beijing 102218,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。